These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3509885)

  • 21. Host metabolites that phenotypically increase the resistance of Haemophilus influenzae type b to clearance mechanisms.
    Kuratana M; Anderson P
    J Infect Dis; 1991 May; 163(5):1073-9. PubMed ID: 2019756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
    Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
    Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of phenotypic variants of Haemophilus influenzae type b to serum bactericidal activity: relation to surface lipopolysaccharide.
    Gilsdorf JR; Ferrieri P
    J Infect Dis; 1986 Feb; 153(2):223-31. PubMed ID: 3484771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide.
    Weiser JN; Pan N
    Mol Microbiol; 1998 Nov; 30(4):767-75. PubMed ID: 10094625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity.
    van Schilfgaarde M; Eijk P; Regelink A; van Ulsen P; Everts V; Dankert J; van Alphen L
    Microb Pathog; 1999 May; 26(5):249-62. PubMed ID: 10222210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical characterization and worldwide distribution of serologically distinct lipopolysaccharides of Haemophilus influenzae type b.
    van Alphen L; Klein M; Geelen-van den Broek L; Riemens T; Eijk P; Kamerling JP
    J Infect Dis; 1990 Sep; 162(3):659-63. PubMed ID: 2117626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of otitis media in chinchillas rechallenged with nontypable Haemophilus influenzae and serological response to outer membrane antigens.
    Karasic RB; Trumpp CE; Gnehm HE; Rice PA; Pelton SI
    J Infect Dis; 1985 Feb; 151(2):273-9. PubMed ID: 3871464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protection from infection with Haemophilus influenzae type b by monoclonal antibody to the capsule.
    Gigliotti F; Insel RA
    J Infect Dis; 1982 Aug; 146(2):249-54. PubMed ID: 6980957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental recurrent otitis media induced by Haemophilus influenzae: protection and serum antibodies.
    Melhus A; Hermansson A; Akkoyunlu M; Forsgren A; Prellner K
    Am J Otolaryngol; 1995; 16(6):383-90. PubMed ID: 8572254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterohybridomas secreting human monoclonal antibodies against Haemophilus influenzae type b.
    Martin D; Larose Y; Hamel J; Lagacé J; Brodeur BR
    Eur J Immunol; 1988 Apr; 18(4):601-6. PubMed ID: 3259187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface changes in Haemophilus influenzae type b associated with a phenotypic increase in resistance to bactericidal antibody.
    Loeb MR; Kuratana M; Anderson P
    J Infect Dis; 1992 Jun; 165 Suppl 1():S110-1. PubMed ID: 1588139
    [No Abstract]   [Full Text] [Related]  

  • 32. Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease.
    Sethi S; Wrona C; Grant BJ; Murphy TF
    Am J Respir Crit Care Med; 2004 Feb; 169(4):448-53. PubMed ID: 14597486
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response to Haemophilus influenzae type b lipooligosaccharide in infants with Haemophilus meningitis.
    Patrick CC; McCracken GH; Hansen EJ
    J Infect Dis; 1987 Sep; 156(3):516-20. PubMed ID: 3497210
    [No Abstract]   [Full Text] [Related]  

  • 34. Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae.
    Clark SE; Snow J; Li J; Zola TA; Weiser JN
    PLoS Pathog; 2012; 8(3):e1002521. PubMed ID: 22396641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unexpected effects of absorbed normal rabbit serum and bovine serum albumin on survival of Haemophilus influenzae type b in the infant rat.
    Loeb MR
    Microb Pathog; 1988 Jan; 4(1):9-13. PubMed ID: 3264378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b.
    Amir J; Liang X; Granoff DM
    Pediatr Res; 1990 Apr; 27(4 Pt 1):358-64. PubMed ID: 2342828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fundamental studies on rapid detection of Haemophilus influenzae by enzyme-linked immunosorbent assay (ELISA)].
    Hoshino H; Nishiyama N; Uesaka Y; Horigome K; Sugahara K; Yamaguchi K
    Kansenshogaku Zasshi; 1989 May; 63(5):471-8. PubMed ID: 2506302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotypic and genetic variation in the susceptibility of Haemophilus influenzae type b to antibodies to somatic antigens.
    Anderson P; Flesher A; Shaw S; Harding AL; Smith DH
    J Clin Invest; 1980 Apr; 65(4):885-91. PubMed ID: 6153662
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of monoclonal antibodies recognizing three distinct, phosphorylated carbohydrate epitopes in the lipopolysaccharide of the deep rough mutant I-69 Rd-/b+ of Haemophilus influenzae.
    Rozalski A; Brade L; Kosma P; Moxon R; Kusumoto S; Brade H
    Mol Microbiol; 1997 Feb; 23(3):569-77. PubMed ID: 9044290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement-mediated early clearance of Haemophilus influenzae type b from blood is independent of serum lytic activity.
    Noel GJ; Katz S; Edelson PJ
    J Infect Dis; 1988 Jan; 157(1):85-90. PubMed ID: 3257245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.